The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, is paying especial attention to the developments in the fifth case involving Fosamax and a painful condition known as osteonecrosis of the jaw to go to trial, now underway.
Read the full story
“The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the drug Fosamax, notes with commingled optimism and circumspection a new report that some troubled drugs, including Fosamax, might aid in the treatment of certain cancers.”
Read the full story